Literature DB >> 17102904

Chymase increases glomerular albumin permeability via protease-activated receptor-2.

Ram Sharma1, Vidudala Prasad, Ellen T McCarthy, Virginia J Savin, Kottarappat N Dileepan, Daniel J Stechschulte, Elias Lianos, Thomas Wiegmann, Mukut Sharma.   

Abstract

Increased infiltration of the kidney by mast cells is associated with proteinuria, and interstitial fibrosis in various renal diseases. Mast cells produce serine proteases including tryptase and chymase (MCC) that act via protease-activated receptors (PARs) to induce synthesis of fibrogenic cytokines by renal cells. In the present study, we investigated direct effect of MCC and role of PARs on glomerular albumin permeability (P(alb)). Isolated rat glomeruli were incubated with MCC (0.1, 1, 10, and 100 ng/ml) for 5-30 min in presence or absence of PAR-1 and PAR-2 blocking antibodies. P(alb) was determined from the change in glomerular volume in response to an albumin oncotic gradient. The effect of direct activation of PARs on P(alb) was verified by incubating glomeruli with synthetic hexapeptide known to activate PAR-1 and PAR-2. MCC increased P(alb) of isolated rat glomeruli in a dose- and time-dependent manner. Blocking PAR-2 prevented MCC-mediated increase in P(alb). RT-PCR analysis of glomerular RNA demonstrated the presence of constitutively expressed PAR-1, -2, and -3 and low levels of PAR-4. In addition, direct activation of PAR-2 by hexapeptide SLIGKV increased P(alb) comparable to MCC, whereas PAR-1 activation by TFLLRN had no effect on P(alb). Our results document that MCC induces increase in P(alb) and that this effect is mediated through PAR-2. MCC may also play a role in renal scarring. We propose that inhibiting MCC activity or blocking the activation of PAR-2 may provide new targets for therapy in renal diseases.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17102904     DOI: 10.1007/s11010-006-9342-0

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  48 in total

1.  Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats.

Authors:  Annette J Dahly-Vernon; Mukut Sharma; Ellen T McCarthy; Virginia J Savin; Steven R Ledbetter; Richard J Roman
Journal:  Hypertension       Date:  2005-02-21       Impact factor: 10.190

2.  Role of mast cells in experimental anti-glomerular basement membrane glomerulonephritis.

Authors:  Kathrin Hochegger; Frank Siebenhaar; Volker Vielhauer; Dorothea Heininger; Tanya N Mayadas; Gert Mayer; Marcus Maurer; Alexander R Rosenkranz
Journal:  Eur J Immunol       Date:  2005-10       Impact factor: 5.532

3.  Quantitative analysis of the interstitial mast cells in idiopathic mesangiocapillary glomerulonephritis type I.

Authors:  M Danilewicz; M Wagrowska-Danilewicz
Journal:  Nefrologia       Date:  2001 May-Jun       Impact factor: 2.033

Review 4.  Local angiotensin II-generating system in vascular tissues: the roles of chymase.

Authors:  M Miyazaki; S Takai
Journal:  Hypertens Res       Date:  2001-05       Impact factor: 3.872

5.  Effect of endothelin-1(1-31) on p38 mitogen-activated protein kinase in cultured human mesangial cells.

Authors:  D Inui; M Yoshizumi; Y Suzaki; K Kirima; K Tsuchiya; H Houchi; S Kagami; T Tamaki
Journal:  Life Sci       Date:  2000-12-29       Impact factor: 5.037

6.  Molecular cloning of a potential proteinase activated receptor.

Authors:  S Nystedt; K Emilsson; C Wahlestedt; J Sundelin
Journal:  Proc Natl Acad Sci U S A       Date:  1994-09-27       Impact factor: 11.205

7.  Protease-activated receptor 3 is a second thrombin receptor in humans.

Authors:  H Ishihara; A J Connolly; D Zeng; M L Kahn; Y W Zheng; C Timmons; T Tram; S R Coughlin
Journal:  Nature       Date:  1997-04-03       Impact factor: 49.962

8.  Contribution of mast cells to the tubulointerstitial lesions in IgA nephritis.

Authors:  T Ehara; H Shigematsu
Journal:  Kidney Int       Date:  1998-11       Impact factor: 10.612

9.  Marked species-difference in the vascular angiotensin II-forming pathways: humans versus rodents.

Authors:  H Okunishi; Y Oka; N Shiota; T Kawamoto; K Song; M Miyazaki
Journal:  Jpn J Pharmacol       Date:  1993-06

10.  Constitutive expression of functionally active protease-activated receptors 1 and 2 in human conjunctival epithelial cells.

Authors:  Timothy J Nickel; Mohammad H Kabir; Jaya Talreja; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

View more
  13 in total

1.  Mouse mast cell protease-4 deteriorates renal function by contributing to inflammation and fibrosis in immune complex-mediated glomerulonephritis.

Authors:  Lisa Scandiuzzi; Walid Beghdadi; Eric Daugas; Magnus Abrink; Neeraj Tiwari; Cristiana Brochetta; Julien Claver; Nassim Arouche; Xingxing Zang; Marina Pretolani; Renato C Monteiro; Gunnar Pejler; Ulrich Blank
Journal:  J Immunol       Date:  2010-06-07       Impact factor: 5.422

Review 2.  Coagulation, protease-activated receptors, and viral myocarditis.

Authors:  Silvio Antoniak; Nigel Mackman
Journal:  J Cardiovasc Transl Res       Date:  2013-11-08       Impact factor: 4.132

3.  Mast cells regulate homeostatic intestinal epithelial migration and barrier function by a chymase/Mcpt4-dependent mechanism.

Authors:  Katherine R Groschwitz; Richard Ahrens; Heather Osterfeld; Michael F Gurish; Xiaonan Han; Magnus Abrink; Fred D Finkelman; Gunnar Pejler; Simon P Hogan
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-16       Impact factor: 11.205

Review 4.  Endothelin-converting enzyme-1 inhibition and renoprotection in end-stage renal disease.

Authors:  Sanjaya Kuruppu; Niwanthi W Rajapakse; A Ian Smith
Journal:  Pflugers Arch       Date:  2013-01-18       Impact factor: 3.657

Review 5.  Mast cell chymase and tryptase in abdominal aortic aneurysm formation.

Authors:  Yi Wang; Guo-Ping Shi
Journal:  Trends Cardiovasc Med       Date:  2012-08-14       Impact factor: 6.677

6.  Impact of Mast Cell Chymase on Renal Disease Progression.

Authors:  Haimanot Wasse; Nawazish Naqvi; Ahsan Husain
Journal:  Curr Hypertens Rev       Date:  2012-02-01

7.  Chymase-mediated intestinal epithelial permeability is regulated by a protease-activating receptor/matrix metalloproteinase-2-dependent mechanism.

Authors:  Katherine R Groschwitz; David Wu; Heather Osterfeld; Richard Ahrens; Simon P Hogan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2013-01-10       Impact factor: 4.052

Review 8.  Protease-activated receptors and itch.

Authors:  Tasuku Akiyama; Ethan A Lerner; E Carstens
Journal:  Handb Exp Pharmacol       Date:  2015

9.  The Role of Angiotensin II in Glomerular Volume Dynamics and Podocyte Calcium Handling.

Authors:  Daria V Ilatovskaya; Oleg Palygin; Vladislav Levchenko; Bradley T Endres; Alexander Staruschenko
Journal:  Sci Rep       Date:  2017-03-22       Impact factor: 4.379

10.  Chymase inhibition retards albuminuria in type 2 diabetes.

Authors:  Benjamin J Bivona; Shinji Takai; Dale M Seth; Ryousuke Satou; Lisa M Harrison-Bernard
Journal:  Physiol Rep       Date:  2019-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.